Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
Low risk of type-specific carcinogenic HPV re-appearance with subsequent cervical intraepithelial neoplasia grade 2/3.
复制标题
DOI:
10.1002/ijc.27418
复制
发表时间:
2012-10-15
影响因子:
6.4
通讯作者:
Burk, Robert D.
中科院分区:
文献类型:
--
作者:
Cecilia Rodriguez, Ana;Schiffman, Mark;Herrero, Rolando;Hildesheim, Allan;Bratti, Concepcion;Sherman, Mark E.;Solomon, Diane;Guillen, Diego;Alfaro, Mario;Morales, Jorge;Hutchinson, Martha;Cheung, Li;Wacholder, Sholom;Burk, Robert D.
Carcinogenic human papillomavirus (HPV) infections are very common after sexual debut and nearly all become undetectable (“clear”) within a few years. Following clearance, the long-term risks of type-specific HPV re-appearance and subsequent risk of cervical intraepithelial neoplasia grade 2 or worse (CIN2+) are not well defined. In the 7-year, population-based cohort study in Guanacaste, Costa Rica, we studied how often type-specific carcinogenic HPV infections re-appeared after clearance, and how often re-appearance led to CIN2+. We considered 1740 carcinogenic HPV infections detected by MY09/11 PCR among 2805 women (18-91 years old, median 34) who were actively followed at 6- or 12-month intervals. We identified women with 1 or more type-specific HPV infections that cleared and re-appeared, and further defined a subgroup of “definite clearance and re-appearance” (≥ 2 intervening negative results over a period of ≥ 1 year). We determined the absolute risk of CIN2+ among the different groups. P values are two sided. Only 7.7% (81/1052) of HPV-infected women had intervening negative results. Very few (3.7%, 39/1052) had “definite clearance and re-appearance”, of which 5.1% (2/39) subsequently persisted to a diagnosis of CIN2. There were zero CIN3+ lesions. Extremely few women (2/2805 of women in our cohort) had a type-specific carcinogenic HPV infection clear, re-appear and lead to CIN2+. If confirmed, this argues against vaccination to avoid re-appearance that leads to precursor lesions and against the need of frequent HPV screening after initial negative results.
登录
查看更多内容
影响因子:
11.2
作者:
Goodman MT;Shvetsov YB;McDuffie K;Wilkens LR;Zhu X;Thompson PJ;Ning L;Killeen J;Kamemoto L;Hernandez BY
通讯作者:
Hernandez BY
影响因子:
51.1
作者:
Cogliano, V;Baan, R;El Ghissassi, F
通讯作者:
El Ghissassi, F
DOI:
10.1158/1055-9965.epi-10-1108
发表时间:
2011-04
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Winer RL;Hughes JP;Feng Q;Xi LF;Cherne S;O'Reilly S;Kiviat NB;Koutsky LA
通讯作者:
Koutsky LA
影响因子:
120.7
作者:
Moscicki, AB;Hills, N;Palefsky, J
通讯作者:
Palefsky, J
影响因子:
6.4
作者:
Plummer, Martyn;Schiffman, Mark;Wheeler, Cosette M.
通讯作者:
Wheeler, Cosette M.